it's time to live in a world with less pain.

Next generation non-opioid pain therapeutics

​CERSCI Therapeutics is focused on developing next-generation non-opioid pain therapeutics for the treatment and prevention of acute and chronic pain. Our novel chemistry and biological targets offer the potential for first-in-class disease-modifying therapeutics for pain. 



The addressable worldwide market for pain pharmaceuticals is over $30B annually, growing at 12% CAGR. Recognition of the opioid epidemic is creating substantial opportunities for new therapies providing efficacious and safe non-opioid pain management alternatives. Opioids are dangerous and addictive, and non-opioid alternatives on the market are plagued with unwanted side effects including: sedation, cognitive impairment, blurred vision, constipation, sexual dysfunction, and tachycardia. According to the Centers for Disease Control, 78 people die every day from an overdose of prescription painkillers. Patients and health care workers are hungry for new solutions.



CERSCI is developing potent adenosine monophosphate-activated protein kinase (AMPK) activators, and peroxynitrite (PN) scavengers for the treatment and prevention of acute and chronic pain.  CERSCI’s technology is protected by issued and pending patents.